Skip to main content
. Author manuscript; available in PMC: 2015 Sep 21.
Published in final edited form as: Leukemia. 2011 Jul 15;25(12):1808–1814. doi: 10.1038/leu.2011.157

Figure 1.

Figure 1

Change in γH2AX in patient peripheral blood blasts at 2 h following vosaroxin treatment in the weekly schedule on days 1 and 8 (50 mg/m2, n=1; 60 mg/m2, n=2; 72 mg/m2, n=5; 90 mg/m2, n=2) at one study center. Responders (filled symbols: 50 mg/m2, n=1; 60 mg/m2, n=1; 72 mg/m2, n=1; 90 mg/m2, n=2) had bone marrow blasts <5% after treatment and non-responders (open symbols: 60 mg/m2, n=1; 72 mg/m2, n=4) had bone marrow blasts ≥5% after treatment.